As expected, survivin upregulation is highly associated with pathogenesis, resistance to chemo- and radiotherapies, and poor prognosis for a variety of human malignancies, including CRC [12,13,14,15,16,17,18]. The gene discussed is BIRC5; the disease is colorectal carcinoma.